Eastgate Biotech Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
-
-
-
132.00
-
Cost of Goods Sold (COGS) incl. D&A
-
14.50
27.90
63.40
-
Gross Income
-
14.50
27.90
68.60
-
SG&A Expense
605.80
1,641.60
4,790.90
4,240.00
2,633.50
EBIT
605.80
1,656.10
4,818.80
4,171.40
2,633.50
Unusual Expense
-
-
-
-
184.40
Interest Expense
17.00
64.20
88.90
109.90
159.60
Pretax Income
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Consolidated Net Income
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Net Income
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Net Income After Extraordinaries
622.80
1,720.30
4,907.70
4,281.30
2,977.50
Net Income Available to Common
622.80
1,720.30
4,907.70
4,281.30
2,977.50
EPS (Basic)
0.03
0.05
0.10
0.02
0.01
Basic Shares Outstanding
23,865.40
31,625.00
49,526.10
191,504.20
304,795.50
EPS (Diluted)
0.03
0.05
0.10
0.02
0.01
Diluted Shares Outstanding
23,865.40
31,625.00
49,526.10
191,504.20
304,795.50
EBITDA
605.80
1,641.60
4,790.90
4,127.10
2,633.50
About Eastgate Biotech
View Profile
